Radius Health Announces Fourth Quarter and Full-Year 2018 Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
Radius Health (RDUS) Tops Q4 EPS by 51c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Below Consensus
February 28, 2019 4:30 PM ESTRadius Health (NASDAQ: RDUS) reported Q4 EPS of ($0.66), $0.51 better than the analyst estimate of ($1.17). Revenue for the quarter came in at $34.4 million versus the consensus estimate of $33.01 million.
I am very pleased with the continued strong performance of TYMLOS in the U.S.... More
